Search research articles
Contact Us
Filters
Showing results (711-720 of 726) with videos related to
Page
of 73
Sort By:
Journal of Medicinal Chemistry
|
August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate
William N Washburn, Mark Manfredi, Pratik Devasthale, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Physical Review Letters
|
May 9, 2015
Observation of Parametric Instability in Advanced LIGO
Matthew Evans, Slawek Gras, Peter Fritschel, et al.
NPJ Precision Oncology
|
June 29, 2026
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis
Marie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, et al.
Pneumologie (Stuttgart, Germany)
|
October 26, 2023
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]
Wolfgang Schütte, Sylvia Gütz, Wiebke Nehls, et al.
Nature Medicine
|
February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
JAMA Oncology
|
July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)
Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
Cancer Discovery
|
July 12, 2018
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERα<sup>WT</sup> and ERα<sup>MUT</sup> Breast Cancer
Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
Susan Wyllie, Stephen Brand, Michael Thomas, et al.
Micropublication Biology
|
March 3, 2025
The <i>M.3.2</i> mutation in <i>Drosophila melanogaster</i> mapped as a novel allele of <i>tout-velu</i>
MacKenzie Patterson, Adriana R Andrus, Conner Bell, et al.
Page
of 73
Search research articles
Search
Showing results (711-720 of 726) with videos related to
Sort By:
Page
of 73
Journal of Medicinal Chemistry
|
August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate
William N Washburn, Mark Manfredi, Pratik Devasthale, et al.
Journal of Medicinal Chemistry
|
August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Physical Review Letters
|
May 9, 2015
Observation of Parametric Instability in Advanced LIGO
Matthew Evans, Slawek Gras, Peter Fritschel, et al.
NPJ Precision Oncology
|
June 29, 2026
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis
Marie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, et al.
Pneumologie (Stuttgart, Germany)
|
October 26, 2023
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]
Wolfgang Schütte, Sylvia Gütz, Wiebke Nehls, et al.
Nature Medicine
|
February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
JAMA Oncology
|
July 9, 2026
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320)
Farastuk Bozorgmehr, Inn Chung, Rouven Behnisch, et al.
Cancer Discovery
|
July 12, 2018
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERα<sup>WT</sup> and ERα<sup>MUT</sup> Breast Cancer
Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
Susan Wyllie, Stephen Brand, Michael Thomas, et al.
Micropublication Biology
|
March 3, 2025
The <i>M.3.2</i> mutation in <i>Drosophila melanogaster</i> mapped as a novel allele of <i>tout-velu</i>
MacKenzie Patterson, Adriana R Andrus, Conner Bell, et al.
Page
of 73